Chronodisruption and melatonin: The need for sensible exposure metrics in epidemiological studies

Journal of Pineal Research

Volumn 45, Issue 3, 2008, Pages 335-336

  Erren, Thomas C ^a   Reiter, Russel J ^b   Piekarski, Claus ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLEAMINE; MELATONIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; CANCER RESEARCH; CANCER RISK; CARCINOGENESIS; CELL DEATH; CIRCADIAN RHYTHM; ENDOMETRIUM CANCER; HUMAN; METASTASIS; NONHUMAN; NOTE; PROSTATE CANCER;

CHRONOBIOLOGY DISORDERS; DATA INTERPRETATION, STATISTICAL; EPIDEMIOLOGIC STUDIES; HUMANS; MELATONIN; NEOPLASMS;

EID: 51649123541     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2008.00599.x     Document Type: Note

References (12)

1. Erren TC, Pape HG, Reiter RJ, Piekarski C. Chronodisruption and cancer. Naturwissenschaften 2008 95: 367 382.
2. Erren TC, Reiter RJ, Piekarski C. Light, timing of biological rhythms, and chronodisruption in man. Naturwissenschaften 2003 90: 485 494.
3. Reiter RJ. Mechanisms of cancer inhibition by melatonin. J Pineal Res 2004 37: 213 214.
4. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000 10: 57 70.
5. Erren TC. Could visible light contribute to the development of leukaemia and other cancers in children? Med Hypotheses 2005 64: 864 871.
6. Straif K, Baan R, Grosse Y et al., on behalf of the WHO International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 2007 8: 1065 1066.
7. Doll R. Introduction and overview. In: Epidemiology of lung cancer. Lung biology and health and disease, Vol. 74. Samet JM, ed. Marcel Dekker, Inc., New York-Basel-Hong Kong, 1994 pp. 10 11.
8. Viswanathan AN, Hankinson SE, Schernhammer ES. Night shift work and the risk of endometrial cancer. Cancer Res 2007 67: 10618 10622.
9. Arendt J. Melatonin. Clin Endocrinol 1988 29: 205 229.
10. Dubocovich M, Markowska M. Functional melatonin MT1 and MT2 receptors in mammals. Endocr 2005 27: 89 100.
11. Jung B, Ahmad N. Melatonin in cancer management: Progress and promise. Cancer Res 2006 66: 9787 9793.
12. Erren TC, Pape HG, Piekarski C, Reiter RJ. Not all shifts are equal: it's time for comprehensive exposure metrics in chronodisruption research. Cancer Res 2008 68.